Stock Market Reviews

DBVT (DBV Technologies S.A.) News

Get the latest news, insights, and market updates on DBVT (DBV Technologies S.A.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading
  European equities traded in the US as American depositary receipts were trending lower late Tuesday
  Feb 3, 2026 - $DBVT
• European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
  European equities traded in the US as American depositary receipts opened the week higher, rising 0.
  Feb 2, 2026 - $DBVT
• European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Up 1.4% for Week
  European equities traded in the US as American depositary receipts were tracking higher late Friday
  Jan 23, 2026 - $DBVT
• European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading
  European equities traded in the US as American depositary receipts were tracking lower late Tuesday
  Jan 20, 2026 - $DBVT
• Why DBV Technologies (ENXTPA:DBV) Is Up 21.7% After Extending Its VIASKIN Peanut Funding Runway
  DBV Technologies previously announced that it had raised €166.7 million in gross proceeds from the full exercise of warrants issued in its March 2025 financing, resulting in the creation of tens of millions of new shares and second pre-funded warrants. This cash injection, which management believes secures at least 12 months of operational funding, is earmarked to support working capital, a potential Biologics License Application for VIASKIN Peanut, and commercial launch preparations in the...
  Jan 19, 2026 - $DBVT
• European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; Rise 2% for Week
  European equities traded in the US as American depositary receipts were down late Friday morning, fa
  Jan 16, 2026 - $DBVT
• DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing
  Châtillon, France, January 16, 2026 DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing The Company is sufficiently funded to support operations and commercial preparedness, including infrastructure buildup, to launch the VIASKIN® Peanut patch in children 4 to 7 years old in the U.S., if approved. DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Capital Market: DBVT) (the “Com
  Jan 16, 2026 - $DBVT
• European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading
  European equities traded in the US as American depositary receipts were little changed late Thursday
  Jan 15, 2026 - $DBVT
• European Equities Traded in the US as American Depositary Receipts Rise Slightly in Tuesday Trading
  European equities traded in the US as American depositary receipts were heading slightly higher late
  Jan 13, 2026 - $DBVT
• Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
  Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Notice:This document supersedes and replaces the information previously published on January 5, 2026, to account for the earlier exercise of various securities instruments, in connection with the Company’s employee stock ownership plans and warrants from a previous financing transaction. Market
  Jan 12, 2026 - $DBVT